Enrin s.r.o.

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for atherosclerotic cardiovascular disease and related conditions. The center's work in this area aims to reduce the risk of major adverse cardiovascular events, including cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and urgent coronary revascularization.

• Innovative therapies for elevated lipoprotein(a)
• Prevention of major adverse cardiovascular events
• Advanced cardiovascular risk management

Through cutting-edge research, the center is contributing to the development of new therapeutic strategies that aim to improve patient outcomes and enhance quality of life for those with cardiovascular conditions.

Specializing in the intersection of metabolic disorders and renal health, the center is dedicated to exploring the effects of innovative treatments on obesity and its complications. The research focuses on reducing the incidence of serious heart-related complications and preventing the worsening of kidney function.

• Impact of obesity on cardiovascular and renal outcomes
• Novel interventions for metabolic health
• Prevention of kidney function deterioration

By advancing understanding in these areas, the center is paving the way for new approaches to managing obesity and its associated health risks, ultimately aiming to improve long-term health outcomes for affected individuals.